GH: We Are Removing Guardant Health from Investing Ideas

12/17/19 03:37PM EST

A quick note from Hedgeye CEO Keith McCullough:

On today’s +4% pop GH is signaling immediate-term TRADE #overbought and I think we can come back to this one at a lower price. This is a risk management decision, not a fundamental research one.

***No change to Healthcare analyst Tom Tobin's fundamental long thesis on Guardant Health. Click here to read our analyst's original report.

© 2024 Hedgeye Risk Management, LLC. The information contained herein is the property of Hedgeye, which reserves all rights thereto. Redistribution of any part of this information is prohibited without the express written consent of Hedgeye. Hedgeye is not responsible for any errors in or omissions to this information, or for any consequences that may result from the use of this information.